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Abstract
Background: Pathology of white matter in brains of patients with major depressive disorder (MDD) is well-documented, but
the cellular and molecular basis of this pathology are poorly understood.
Methods: Levels of DNA oxidation and gene expression of DNA damage repair enzymes were measured in Brodmann area
10 (BA10) and/or amygdala (uncinate fasciculus) white matter tissue from brains of MDD (n=10) and psychiatrically normal
control donors (n=13). DNA oxidation was also measured in BA10 white matter of schizophrenia donors (n=10) and in
prefrontal cortical white matter from control rats (n=8) and rats with repeated stress-induced anhedonia (n=8).
Results: DNA oxidation in BA10 white matter was robustly elevated in MDD as compared to control donors, with a smaller
elevation occurring in schizophrenia donors. DNA oxidation levels in psychiatrically affected donors that died by suicide
did not significantly differ from DNA oxidation levels in psychiatrically affected donors dying by other causes (non-suicide).
Gene expression levels of two base excision repair enzymes, PARP1 and OGG1, were robustly elevated in oligodendrocytes
laser captured from BA10 and amygdala white matter of MDD donors, with smaller but significant elevations of these gene
expressions in astrocytes. In rats, repeated stress-induced anhedonia, as measured by a reduction in sucrose preference, was
associated with increased DNA oxidation in white, but not gray, matter.
Conclusions: Cellular residents of brain white matter demonstrate markers of oxidative damage in MDD. Medications that
interfere with oxidative damage or pathways activated by oxidative damage have potential to improve treatment for MDD.
Keywords: oxidative stress, DNA, messenger RNA, anhedonia, oligodendrocyte
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Significance Statement
Currently available antidepressants produce remission in only two-thirds of patients with depression, a disorder that affects over
10 million people in the US each year. The proposed study deviates from traditional studies of the pathobiology of depression
that focus on systems directly affected by current and less than adequate antidepressants. This study unearths vulnerabilities of
oligodendrocytes in brain white matter in major depressive disorder. Oligodendrocytes are critical for the transmission of information from one region of the brain to another. The findings provide a theoretical cellular and molecular basis for brain white
matter pathology observed in living patients with depression by in vivo brain imaging. Further study of the affected pathways
in oligodendrocytes has the potential to uncover novel targets for drugs that could prevent or reverse white matter pathology in
depression, and ultimately improve overall treatment of this disorder.

Introduction
Brain white matter pathology is a feature of several psychiatric
diseases, including major depressive disorder (MDD) and bipolar
disorder. In living patients, white matter pathology has been intimated by in vivo imaging studies, including diffusion tensor imaging (DTI) to ascertain anisotropy and diffusivity in white matter
and T2- or proton density weighted images from MRI to measure white matter hyper-intensities or white matter volumes.
Abnormalities in DTI, including reduced anisotropy, and elevated
numbers of white matter hyper-intensities have been reported in
MDD patients (Taylor et al., 2007; Tham et al., 2011). The cellular
basis of white matter abnormalities has not been conclusively
identified, but is thought to be a result of pathology of myelinating cells (oligodendrocytes), vascular tissues (especially in the
elderly), astrocytes, and/or microglia that reside in white matter
regions of the brain. In MDD, cellular abnormalities have been
reported in white matter obtained postmortem from depressed
patients who died by suicide as compared to individuals dying
from other medical causes and lacking a psychiatric diagnosis.
These abnormalities include alterations in astrocyte morphology (Torres-Platas et al., 2011), reduced myelin staining (Regenold
et al., 2007), and aberrations in oligodendrocyte gene expressions
and morphology (Szebeni et al., 2014; Rajkowska et al., 2015).
Recently, we discovered shortened telomeres in white matter oligodendrocytes collected from postmortem brains of MDD
donors, as compared to age-matched psychiatrically normal
control donors (Szebeni et al., 2014). Mechanisms contributing
to telomere shortening in other cell types include cell divisions
and telomere DNA damage mediated by oxidation events (Von
Zglinicki, 2002). Since oligodendrocytes are post-mitotic, we
speculated that telomere shortening in oligodendrocytes from
MDD subjects may be secondary to oxidative damage of telomere DNA. Evidence of oxidative damage in MDD includes a
wealth of support such as elevated biological products of oxidative stress (Forlenza and Miller, 2006; Bilici et al., 2001; Selley,
2004; Sarandol et al., 2006, 2007; Dimopoulos et al., 2008; Yager
et al., 2010) and reduced plasma concentrations of free radical
scavengers (Peet et al., 1998; Maes et al., 2000; Owen et al., 2005).
The primary targets of reactive oxygen on DNA are oxidationsensitive guanine nucleotides due to their low ionization potential in comparison to other nucleic acid bases (Kawanishi et al.,
2001). Guanine-rich areas of DNA, such as telomere DNA and
promoter/enhancer areas of genes, are thereby particularly sensitive to oxidative attack. One of the fastest cellular responses
to oxidative damage of DNA is poly(ADP-ribosyl)ation, a posttranslational modification of nuclear proteins, catalyzed by the
nuclear enzyme poly(ADP)-ribose polymerase-1 (PARP1) (Gibson
and Kraus, 2012). In the CNS, PARP1 is ubiquitously distributed
in glia and neurons, found predominantly in the nucleus, and
exerts a vast array of nuclear effects that influence the process
of DNA repair. When DNA is oxidized, 8-oxoG DNA glycosylase

(encoded by OGG1) excises oxidized nucleotides (Hazra et al.,
2001). Gene expression of PARP1 and OGG1 is upregulated by oxidative stress (Liu et al., 2000; Lan et al., 2003; Adaikalakoteswari
et al., 2007). Hence, PARP1 and OGG1 are two key mediators
of the cellular apparatus for base excision and repair (BER) in
response to oxidative attack of DNA.
Our previous work (Szebeni et al., 2014) demonstrating telomere shortening in white matter oligodendrocytes from MDD
brain donors strongly implicates elevated levels of DNA oxidation of white matter in MDD. In the present study, we wished to
confirm this by directly measuring a common product of DNA
oxidation, 8-hydroxy-deoxyguanosine (8OHdG), in white matter
from MDD donors. Since nearly all MDD donors studied previously (Szebeni et al., 2014) died by suicide, it seemed important to
determine whether biological factors specific to suicidal behavior, rather than depression, might contribute to vulnerabilities
to DNA oxidation. To evaluate this, MDD donors that died as a
result of suicide or natural medical deaths were included in the
present study. To increase the sample size of the non-suicide vs
suicide comparison, we also evaluated DNA oxidation in a group
of schizophrenia brain donors that died as a result of suicide or
natural medical deaths. Given the roles of PARP1 and OGG1 in
DNA damage repair, levels of expression of PARP1 and OGG1 were
evaluated in specific white matter cell populations collected by
laser capture microdissection from MDD and psychiatrically normal control brain donors. In addition, white matter DNA oxidation was studied in rats that demonstrated anhedonia following
repeated exposure to both social defeat stress and chronic unpredictable stress, to examine DNA oxidation associated with anhedonia in the absence of the many variables that can complicate
human postmortem brain tissue studies. The results of this study
provide further evidence for oxidative damage of white matter
oligodendrocytes in MDD, implicating oligodendrocyte pathology
as a contributory factor in the psychopathology of MDD.

Methods
Human Subjects and Tissue Acquisition
The methods for obtaining tissues from psychiatrically characterized brain donors is exactly as described previously (Chandley
et al., 2013). Briefly, tissues are obtained at autopsy at the
Medical Examiner’s Office of Cuyahoga County, OH (USA) using
an approved Institutional Review Board protocol. Axis I diagnoses according to the Diagnostic and Statistical Manual of Mental
Disorders (4th ed.) (DSM-IV) (American Psychiatric Association,
1994) were established following structured interviews of next-ofkin of all subjects using the Structured Clinical Interview for DSM
Axis I Disorders modified for third-person reporting (First et al.,
1996). Table 1 shows demographic information of brain donors.
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Table 1. Subject Demographics
Subject Code

Gender

pH

RINa

PMIb

Smoker

Toxicology

Axis I Diagnosis

Suicide

Tissue

Assay

6.47
6.49

7.3
6.9

17.0
23.0

No
No,hxd

None
None

No
No

UFe, BA10
UF, BA10

Oxf, GEg
Ox, GE

3c
M
6.28
6.4
4c
M
6.42
7.4
5c
M
6.10
7.1
6c
M
6.95
6.8
8c
M
6.76
7.0
9c
M
6.72
6.7
10 c
M
6.88
8.4
11 c
M
6.79
7.6
12 c
M
6.95
7.2
13 c
M
6.80
7.1
14 c
M
6.98
7.4
15 c
M
6.78
7.7
16 c
F
6.57
N/Ah
18 c
M
6.58
N/A
19 c
F
6.59
N/A
20 c
M
6.71
N/A
MEAN
6.66
7.21
SEM
0.06
0.13
Donors with Major Depressive Disorder
1d
M
6.67
6.9
2d
M
6.80
6.8
3d
M
6.48
5.8
4d
M
6.27
7.5
5d
M
6.84
7.0
6d
M
6.26
7.5
8d
M
6.70
6.7
9d
M
6.23
7.0
10 d
M
6.91
8.0
11 d
M
6.32
6.8
12 d
M
6.20
6.7
13 d
M
6.60
6.6
14 d
M
6.24
6.7
15 d
M
6.80
7.2
26 d
M
6.50
N/A
27 d
M
6.67
N/A
MEAN
6.53
6.9
SEM
0.06
0.1
Donors with Schizophrenia
16 d
F
5.74
N/A
17 d
M
6.62
N/A
18 d
M
6.77
N/A
19 d
F
6.58
N/A
20 d
M
6.78
N/A
21 d
M
6.76
N/A
22 d
M
6.71
N/A
23 d
M
6.70
N/A

17.0
11.0
25.0
19.0
11.0
16.0
17.0
6.0
24.0
17.0
9.0
21.0
32.5
22.0
21.0
24.0
18.5
1.5

No
No
No
No
No
No
Yes
No,hx
Yes
Yes
Yes
Yes
No
No
Yes
No

NDDc
Norpropoxyphene,
propoxyphene, oxycodone
None
NDD
Propoxyphene
NDD
NDD
None
NDD
Lidocaine
None
None
NDD
Ethanol
NDD
NDD
Brompheniramine
Ethanol

None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None

No
No
No
No
No
No
No
No
No
No
No
No
No
No
No
No

UF
UF, BA10
UF, BA10
UF, BA10
UF
UF
UF, BA10
UF, BA10
UF
UF
BA10
BA10
BA10
BA10
BA10
BA10

GE
Ox, GE
Ox, GE
Ox, GE
GE
GE
Ox, GE
Ox, GE
GE
GE
Ox, GE
GE
Ox
Ox
Ox
Ox

31.0
20.0
18.0
30.0
11.0
17.0
20.0
21.0
18.0
20.0
30.0
17.0
19.2
26.0
14.0
26.0
21.1
1.5

No
Yes
No
Yes
No
No
No
Hx
Yes
No
Yes
No
Yes
Yes
No
Yes

Ethanol
Acetone
CO 83%
CO 75%
EtOH
NDD
Diphenhydramine
NDD
NDD
Ethanol
Codeine
NDD
Chlorpheniramine
Ethanol
Tolnaftate, brucine
Sertraline, carbamazepine

MDD
MDD
MDD
MDD
MDD
MDD
MDD
MDD
MDD
MDD
MDD
MDD
MDD
MDD
MDD
MDD

Yes
Yes
Yes
Yes
Yes
No
Yes
Yes
Yes
Yes
Yes
Yes
No
Yes
No
No

UF, BA10
UF, BA10
UF
UF, BA10
UF, BA10
UF, BA10
UF
UF
UF, BA10
UF, BA10
UF
UF
BA10
BA10
BA10
BA10

Ox, GE
Ox, GE
GE
Ox, GE
Ox, GE
Ox, GE
GE
GE
Ox, GE
Ox, GE
GE
GE
Ox, GE
GE
Ox
Ox

18.0
16.0
16.0
6.0
10.0
24.0
19.0
15.0

No
Yes
Yes
Yes
Yes
Yes
No
Yes

SCZi
SCZ
SCZ
SCZ
SCZ
SCZ
SCZ
SCZ

No
No
No
No
Yes
Yes
Yes
Yes

BA10
BA10
BA10
BA10
BA10
BA10
BA10
BA10

Ox
Ox
Ox
Ox
Ox
Ox
Ox
Ox

24 d
25 d
MEAN
SEM

24.0
12.2
16.7
1.7

No
Yes

NDD
NDD
NDD
Amoxapine, loxapine
Ethanol
NDD
NDD
Ethanol, cocaine,
diphenydramine
Olanzapine
Olanzapine

SCZ
SCZ

Yes
Yes

BA10
BA10

Ox
Ox

Normal control donors
1c
M
2c
M

M
M

6.70
6.55
6.59
0.08

N/A
N/A
N/A
N/A

RNA integrity number generated by the Agilent Bioanalyzer 2100.
Postmortem interval.
c
No drugs detectable.
d
History.
e
Uncinate fasciculus.
f
DNA oxidation assay.
g
Gene expression assay.
h
Not applicable to donors that were used for only DNA oxidation studies.
i
Schizophrenia.
a
b
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All diagnoses were active at the time of death. Psychiatrically
normal control, MDD and schizophrenia donors were matched
as closely as possible for age, gender, postmortem interval (PMI),
tissue pH and smoking history. Two control donors had current
alcohol abuse at the time of death while four MDD subjects
had comorbid alcohol abuse disorder and one MDD subject had
comorbid alcohol dependence. In addition, two donors that had
schizophrenia had active alcohol abuse. Control donors died as a
result of cardiovascular disease (11), pulmonary emboli (2), homicide (2), aneurysm (1), crushing impact (1), and pancreatitis (1).
MDD donors died as a result of suicide (14), cardiovascular disease
(3), and gunshot wound (1). Donors that had schizophrenia died
as a result of cardiovascular disease (2), pulmonary disease (1),
homicide (1) and suicide (6). The range of ages was 17 to 82 y for
control donors (47.9 ± 4.1 y), 16 to 86 y for MDD donors (50.5 ± 5.0
y), and 16 to 78 y for schizophrenia donors (39.7 ± 5.1 y). All demographic details for each donor are not included in Table 1 to protect the identity of donors. Two frozen brain areas from the right
hemisphere were obtained for study, BA10 including its white
matter and the amygdala containing the uncinate fasciculus.

Measurement of 8OHdG
Frozen human right BA10 tissue was cut on a cryostat microtome
to 50 µm thick sections and then white matter was punch-dissected using a 3.5 mm trephine dissection tool at -20oC. White
matter from rat prefrontal cortex was similarly punch-dissected with a 1.5 mm trephine at the level of Plate 9 (Paxinos
and Watson, 1986). Genomic DNA was isolated from 10 punches
from each species using the QiaAmp DNA microkit (Qiagen,
Valencia, CA). Levels of 8OHdG were measured from the DNA
isolated from white matter tissue using a commercially available ELISA (JaICA, Shizuoka, Japan).

Immunohistochemistry for Laser Capture
Microdissection
Frozen tissue sections (10 μm) cut on cryostat microtome at -20oC
were prepared for laser capture microdissection as previously
described (Ordway et al., 2009), including rapid immunohistochemical staining for 2’,3’-cyclic nucleotide 3’ phosphodiesterase (CNPase; Abcam, Cambridge, MA) at 37ºC and glial fibrillary
acidic protein GFAP (GFAP; Thermo Fisher Scientific, Waltham,
MA) at 22ºC. Following immunostaining, 500 oligodendrocytes
or 500 astrocytes were captured onto CapSure Macro caps
within 2 h for each sample using a ArcturusXT (Thermo Fisher
Scientific, Waltham, MA) and incubated at 42ºC for 30 min in
RNA lysis buffer immediately following capture.

RNA Purification and End-Point PCR
Total RNA extraction, cDNA synthesis and endpoint PCR was
performed as previously described (Szebeni et al. 2014). Genes
used in endpoint PCR included three reference genes (glyceraldehyde-3-phosphate dehydrogenase, GAPDH; 18S ribosomal
1 RNA, RNA18S1; ubiquitin C, UBC), identification genes for
each cell type (CNP; GFAP) and target genes (PARP1, OGG1), see
Supplementary Table S1 for more information including primer
sequences and NCBI accession numbers. All experiments
were performed in triplicate using an Agilent 2200 Tapestation
Instrument (Agilent Technologies, Santa Clara, CA).

Laboratory Animals
The use of animals was approved by the University Committee
on Animal Care. Male Sprague-Dawley rats (Envigo, Inc.,

Indianapolis, IN, USA) weighing 225–250 g upon arrival served as
‘intruders’ in the social defeat paradigm. Animals were individually housed and were provided enrichment per the NIH Guideline
for the Care and Use of Animals. Rats were housed on a 12 h
on/12 on off light/dark cycle in a climate-controlled vivarium.

Female Rat Fallopian Tube Ligature
Fourteen female Sprague-Dawley rats (Envigo, Inc., Indianapolis,
IN) weighing 175–199 g upon arrival were allowed 6 days of habituation to animal colony conditions. Rats then underwent surgery
to ligate the fallopian tubes (Aygen et al., 2002), and then were
allowed 7 days to recover before being mated with a male rat.

Social Defeat Stress (SDS)
Sixteen male Long-Evans hooded rats (‘resident’) were each
mated with a female Sprague-Dawley (ligated) rat for a 7-day
period. On the eighth day, the female was removed, and an
‘intruder’ rat was placed into the cage for a 5 min period. In all
cases, the resident established dominance over the intruder. The
interaction was stopped when a rat demonstrated a supine posture for up to 10 s, had received up to 10 attack bites, or 5 min
had elapsed. SDS was performed daily for 10 consecutive days,
and was performed between 0900 and 1000 h. Controls were
handled by the experimenter each day during this same time
period, but were not exposed to SDS.

Chronic Unpredictable Stress (CUS)
CUS was performed after SDS on the same day, but at random
times either during the day or evening. Unpredictable stressors
included a 10-min cold (18ºC) or a 15-min warm swim (24ºC) that
was conducted in a tank 61 cm in diameter, a tilted cage for 24 h,
restraint stress for 30 min, or 1 h of shaking/crowding. These
different stressors were randomly arranged, given during either
the light or dark cycle and given each day for 10 consecutive
days. All rats were exposed to each of these 5 stressors twice
during the 10-day period. Controls were handled by the experimenter each day during the same time period but not exposed
to the stressor.

Sucrose Preference
Sucrose preference was performed the final three days of stress
induction (days 8–10), using a procedure based on that of D’Aquila
et al (1997). Animals were given two bottles on their cages between
the 1900 and 2100 h on each day that it was performed (the first
2 h of the dark cycle) with one bottle containing tap water and
the other containing 0.8% sucrose. Amounts of sucrose consumed
were calculated as percentages of the total amount of fluid consumed during the 2 h period on each of the 3 days of testing.

Social Interaction Test
The social interaction test was given 24 h after the last social
defeat stress on day 11 of behavioral testing. The interaction test
was conducted exactly as previously described (Brown et al., 2011).

Statistical Analysis
A Grubb’s test was used to remove statistical outliers from each
dataset prior to analyses. Statistical analyses were performed
as indicated using IBM SPSS Statistics (version 23.0) and data
were graphed using GraphPad Prism (version 5.0b, GraphPad

Szebeni et al. |

Software, La Jolla, CA). For analysis of variance, a Bonferronicorrection was applied to limit Type I error in multiple post-hoc
comparisons. All data are expressed as mean ± standard error
of the mean.

Results
DNA Oxidation in Human BA10 White Matter
Levels of 8OHdG in BA10 white matter were significantly
impacted by the psychiatric status of brain donors (F=20.9[2,30],
p=2.1e-6). Using age as a covariate did not alter the outcome
of the analysis. Post hoc comparisons revealed robustly elevated levels of 8OHdG in MDD donors compared to psychiatrically normal control donors, but also significantly elevated
8OHdG levels in schizophrenia donors (Figure 1A). Since
many of the MDD donors and schizophrenia donors died as a
result of suicide, the possibility that oxidation of white matter DNA might be related to suicide rather than psychiatric
disease was evaluated by grouping the two psychiatric illnesses together and comparing those that died as a result
of suicide to those who had non-suicide deaths. This comparison was made with the caveat that schizophrenia donors,
particularly those that may have suicided during an acute
psychosis, are behaviorly very different from MDD donors of
whom none had a history of psychosis. Levels of 8OHdG in
white matter in suicide brain donors were not significantly
different from 8OHdG levels in non-suicide brain donors, but
8OHdG levels were significantly elevated in both suicide and
non-suicide psychiatric groups compared to the normal control group (Figure 1B). Suicide vs non-suicide was also evaluated within each psychiatric diagnosis, albeit the sample
sizes for these comparisons were much smaller. Comparison
of 8OHdG levels in MDD donors dying as a result of suicide
(n=6, 1.96 ± 0.12 ng/ml) to those MDD donors that died of
natural/medical causes (n=4, 2.10 ± 0.21 ng/ml) were not significantly different (t[8]=0.61; p=0.56). Likewise, 8OHdG levels
in schizophrenia donors dying as a result of suicide (n=6, 1.70
± 0.11 ng/ml) was not significantly different from schizophrenia donors that died of natural/medical causes (n=4, 1.71 ±
0.08 ng/ml; t[8]=0.12; p=0.91).
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PARP1 and OGG1 Gene Expression in Human
BA10 Glia
Expression levels of PARP1 and OGG1 were measured in oligodendrocytes and astrocytes collected by laser capture microdissection of BA10 white matter from MDD donors and normal control
donors. Glia were also laser captured from a second white matter region (uncinate fasciculus) that was too small for measurement of DNA oxidation. We had previously observed indirect
evidence of DNA damage in uncinate fasciculus (Szebeni et al.,
2014). Multivariate ANOVA revealed a significant group effect
on PARP1 expression in the two white matter regions (F=41.0[4,9];
p<1x10-5). Using age, RNA integrity (RIN), pH, and PMI as covariates in the analysis did not alter the outcome of the analysis.
Post-hoc Bonferroni adjusted comparisons of MDD to control
donors showed statistically higher expressions of PARP1 in oligodendrocytes in uncinate fasciculus and BA10, and in astrocytes
only in BA10 white matter (Figure 2A and 2B). Similarly, a significant group effect (control vs MDD) was observed for the expression of OGG1 (F=22.6[4,10]; p<1x10-4). As for PARP1 expression, using
covariates in the analysis did not alter the outcome of the analysis. Post-hoc comparisons demonstrated significantly elevated
OGG1 expression in oligodendrocytes in both uncinate fasciculus
and BA10 white matter (Figure 2C). However, no significant difference in levels of OGG1 expression was observed in astrocytes
from the two white matter regions (Figure 2D). In the samples
collected for laser capture microdissection, there were not a sufficient number of MDD donors who had not died as a result of
suicide to statistically evaluate the potential contribution of suicide to gene expression changes. However, for oligodendrocytes
collected from uncinate fasciculus, where there were two nonsuicide donors, PARP1 and OGG1 gene expression levels in both
non-suicide MDD donors were higher than the levels of PARP1
and OGG1 gene expression levels of every control donor.
The potential that PARP1 and OGG1 expression levels were
linked to DNA oxidation levels was examined. As noted in
Methods, DNA oxidation levels were determined in a subset of
brain donors for which gene expressions were measured, i.e.
6–8 donors per group. In these small samples, there were no
significant correlations between DNA oxidation levels in BA10
white matter and gene expression levels of either BER enzyme
in oligodendrocytes or astrocytes from BA10 white matter

Figure 1. Measurement of 8-hydroxydeoxyguanosine (8OHdG) immunoreactivity in homogenates of BA10 white matter from psychiatrically normal control donors
(CON, n=13), major depressive disorder donors (MDD; n=10) and schizophrenia donors (SCHZ; n=10). The two psychiatric groups include suicide and non-suicide causes
of death in panel A. The same data appears in panel B with psychiatric groups divided according to cause of death, i.e. suicide (n=12 consisting of 6 MDD and 6 SCHZ
donors) and non-suicide (n=8 consisting of 4 MDD and 4 SCHZ donors). P values for group comparisons that reached statistical significance are noted.
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Figure 2. Expression levels of BER enzyme genes, PARP1 (panels A and B) and OGG1 (panels C and D) in laser captured oligodendrocytes (panels A and C) and astrocytes
(panels B and D) from BA10 white matter of psychiatrically normal control donors (white bars) and MDD donors (black bars). P values for group comparisons that
reached statistical significance are noted.

when considering data from both study groups (Supplementary
Table S2).
Potential correlations between PARP1 and OGG1 expression
levels were also evaluated. Here, Pearson correlations were computed after grouping together data from the two brain regions,
examining oligodendrocytes and astrocytes separately. Data
from control and MDD donors were also examined separately
because levels of both mRNAs were significantly different
comparing the two donor groups. Levels of PARP1 expression
significantly correlated with OGG1 expression levels in both
oligodendrocytes and astrocytes, and in both control and MDD
donors (Figure 3).

Evaluation of Potential Modifiers of DNA Oxidation
and DNA Repair Enzyme Gene Expression in Human
Postmortem Brain Samples
The potential impact of several demographic and biological
variables on DNA oxidation and gene expression was evaluated. Levels of DNA oxidation modestly correlated with age in
the control group (r=-0.56, p=0.048). However, DNA oxidations
levels did not significantly correlate with age in the psychiatric
groups, whether considered separately (MDD, r=-0.28, p=0.33;
schizophrenia, r=0.34, p=0.33) or when MDD and schizophrenia
donors were grouped together (r=-0.34, p=0.14). To examine a
potential effect of smoking on DNA oxidation, known smokers
and non-smokers were compared regardless of psychiatric status. DNA oxidation levels were not significantly different comparing smokers to non-smokers (t=0.42[27], p=0.967). Likewise,
the potential effect of chronic alcohol exposure was examined
by grouping all alcohol abuse/dependence donors regardless of
psychiatric status (n=9) and comparing to those without alcohol

abuse/dependence (n=24). As such, alcohol exposure had no significant effect on white matter DNA oxidation levels (t=-0.748[31],
p =0.46).
Factors such as age, tissue pH, PMI, and RIN were considered as possible modifiers of gene expression data. None of
these factors were significantly correlated with OGG1 or PARP1
expression levels in oligodendrocytes collected from either the
uncinate fasiculus or BA10 white matter (Supplementary Tables
S3 and S4). The effect of cigarette smoking on PARP1 and OGG1
expression was evaluated by comparing smokers to nonsmokers regardless of psychiatric status. There was no significant
effect of smoking on levels of PARP1 and OGG1 gene expression
(PARP1: F=1.35[8,20]=0.35; OGG1: F1[8,20]=1.142, P=0.38). Comparisons
of age, RIN, PMI, and RIN were made for all group comparisons.
There were no significant differences in group comparisons
for any of these variables for DNA oxidation measurements
(Supplementary Table S5). Likewise, there were no significant
differences between groups for these variables for the gene
expression measurements, with the exception of a modest difference in mean PMI values (p=0.04; Supplementary Table S6).
There were only four female donors available for study, two
control donors and two age-matched schizophrenia donors.
Tissues from these subjects were used to measure DNA oxidation in BA10 white matter (see Table 1). As observed comparing
all schizophrenia donors to control donors, DNA oxidation levels
were higher in female schizophrenia donors (1.74 and 1.90 fg/
ml; average 1.82 fg/ml) as compared to female control donors
(1.00 and 1.29 fg/ml; average 1.14 fg/ml), although the sample
size is too small to permit a statistical comparison.
Finally, the potential relationship between length of illness and DNA oxidation and DNA repair enzyme gene expression was evaluated. No significant correlation between length

Szebeni et al. |

of illness and levels of DNA oxidation were observed for MDD
brain donors (Supplementary Table S7). Likewise, there were no
significant correlations between length of illness and expression
levels of PARP1 or OGG1 (Supplementary Table S7).

Psychological Stress-Induced Depressive Behavior
in Rats
Rats were exposed daily to two classical psychological stressors, social defeat and unpredictable stress, for 10 days. The
rational for a double stress paradigm was to reduce potential for habituation to stressors. Anhedonia was quantified
in stressed and non-stressed control rats using the 2-bottle
sucrose preference task over the last three days of the stress
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paradigm (days 8–10). Social interaction was assessed the day
after the last stressor (day 11). A repeated measures ANOVA
revealed that rats exposed to stress demonstrated a significant
reduction in preference for sweetened water across the three
test days (Figure 4A; F=28.9[1,26], P=1.3 x 10–5). Likewise, time
spent in the interaction zone was also significantly reduced in
stressed rats (Figure 4B; t=2.59[26], P=0.016). DNA oxidation in
white matter from the prefrontal cortex from these rats, measured two days following the last stressor, was significantly
elevated in stressed rats as compared to unstressed controls
(Figure 4C; t=3.7[14], P=0.002). In contrast, no significant change
in levels of DNA oxidation was observed in prefrontal cortical gray matter comparing stressed to control rats (Figure 4C;
t=0.045[14]; P=0.96).

Figure 3. Relationship between expression levels of PARP1 and OGG1 in white matter glia in normal control (panels A and C) and MDD (panels B and D) donors. Each
graph shows gene expression levels in cells laser captured from both uncinated fasciculus and BA10 white matter for each group of subjects. Pearson correlations and
p values are shown.

Figure 4. The effect of repeated exposure to social defeat stress plus unpredictable stress on sucrose preference in the two-bottle choice task (A), time spent in the
interaction zone (B), and DNA oxidation levels (C) measured in prefrontal cortical white and gray matter of rats. For each graph, white bars indicate handled control
rats and black bars indicate stressed rats. Sucrose preference was measured over the last three days (day 8–10) of the stress paradigm (N=14 rats per group). Repeated
measures ANOVA revealed a significant effect of stress on sucrose preference across the three days (p = 1x10-5). Interaction zone times were measured on the 11th day,
24 h after the last social defeat session (N=14 rats per group). DNA oxidation levels were measured two days after the last stressor (day 12) in 8 rats from each of the
same two groups of rats used for the two-bottle choice task and interaction zone measurements. Statistically significant comparisons are shown above the bars for
panels B and C.
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Discussion
The present study demonstrates elevated levels of DNA oxidation in prefrontal cortical (BA10) white matter from brain donors
with an active MDD at the time of death, as compared to psychiatrically normal control donors. The elevated DNA oxidation
in MDD was accompanied by increased levels of expression of
the DNA damage sensor gene PARP1 and the DNA repair gene
OGG1 in white matter oligodendrocytes. Moreover, elevated
DNA oxidation was observed in prefrontal cortical white matter from rats demonstrating anhedonia after repeated exposure
to psychological stress. These novel findings provide evidence
that oxidative damage to white matter may contribute mechanistically to white matter pathologies that have been described
(Tham et al., 2011) in imaging studies of living MDD patients.
Furthermore, DNA oxidation in white matter in MDD may be
linked to psychological stress-induced oxidative stress that
yields damage to vulnerable cell populations in the brain.
The brain is susceptible to damaging effects of ROS, primarily due to a very high rate of metabolism and oxygen consumption, but also because of specific biochemical reactions (Connor
and Menzies, 1996) that generate free radicals. During periods of
elevated ROS, such as in oxidative stress, DNA and other cellular
constituents such as RNA, proteins and lipids are susceptible to
oxidation. Interestingly, numerous studies link MDD to elevated
oxidative stress conditions, but the majority of this evidence
arises from measurements of oxidative stress-related indices in
blood components. For example, elevated levels of lipid peroxidation products (Bilici et al., 2001; Selley, 2004; Sarandol et al.,
2006; Dimopoulos et al., 2008; Yager et al., 2010), DNA oxidation
(Forlenza and Miller, 2006), and shortened telomeres (Simon
et al., 2006; Kinser and Lyon, 2013; Verhoeven et al., 2013), have
been measured in blood components of MDD patients. In addition, reduced plasma concentrations of free radical scavengers
(Maes et al., 2000, 2011; Owen et al., 2005) have also been found
in MDD. Fewer studies have examined indices of oxidative processes in the brains of MDD subjects. Che et al. (2010) demonstrated elevated levels of oxidized RNA in hippocampal neurons
using postmortem tissue from MDD, bipolar disorder and schizophrenia brain donors. DNA oxidation was also examined in
hippocampal neurons, but showed only a trend for an elevation
in MDD donors. Kim HK et al. (2014) reported elevated oxidation
and nitration of proteins in prefrontal cortices from bipolar disorder and schizophrenia brain donors, but no significant effects
were observed in prefrontal cortex of MDD donors. To date, no
study has investigated the potential role of oxidative damage to
white matter in MDD, other than the work by our lab (Szebeni
et al., 2014). Hence, the present study is the first of two studies
to implicate oxidative damage to white matter in the pathology
of MDD.
Myelinating oligodendrocytes are the predominant cell type
in brain white matter. Among cell types in the brain, oligodendrocytes are known to be uniquely vulnerable to oxidative
stress, with extensive lipid membranes being a primary target
of free radicals (Kim and Kim, 1991; Thorburne and Juurlink,
1996), increased oxidative load due to lipid production for myelination, relatively low glutathione reductase enzyme activity (Juurlink et al., 1998), and high levels of iron (Connor and
Menzies, 1996; Thorburne and Juurlink, 1996), a pro-oxidant.
Previously, we found the first preliminary evidence of oxidative
damage to white matter oligodendrocytes in the brain in MDD
(Szebeni et al., 2014). In this previous study, oligodendrocytes,
but not astrocytes, laser captured from two white matter regions
(uncinate fasciculus and BA10) demonstrated shorter relative

telomere lengths in MDD brain donors as compared to psychiatrically normal control subjects. These initial findings led us to
speculate that elevated DNA oxidation may be responsible for
the shorter telomeres in oligodendrocytes from MDD donors.
The present findings demonstrating elevated levels of 8OHdG
in white matter from BA10 of MDD brain donors, support the
hypothesis that shorter telomeres in white matter oligodendrocytes in MDD is a result of elevated DNA oxidation in MDD.
Elevated DNA oxidation was observed in prefrontal cortical
white matter but not gray matter in rats exposed to repeated psychological stress. Differential sensitivity of various brain regions
to oxidative damage is known. For example, the hippocampal
CA1 region of the brain is more vulnerable to oxidative stress
than the hippocampal CA3 region or the cerebral cortex (Wang
et al., 2009). The apparent lack of elevated DNA oxidation in the
gray matter from stressed rats may be a result of the fact that
the fraction of all cells that are oligodendrocytes in white matter is much greater than that fraction in gray matter. In humans,
glia considerably outnumber neurons (approximately 15 to 1) in
cortical white matter, whereas numbers of glia and neurons are
more similar in cortical gray matter (approximately 1.4 glia to
1 neuron) (Azevedo et al., 2009). Considering that oligodendrocytes are uniquely susceptible to oxidiatve stress, DNA oxidation may be occurring in gray matter oligodendrocytes but it is
not detectable because of a signal dilution by other unaffected
glia and neurons.
Since oligodendrocytes are normally susceptible to oxidative damage, elevated levels of DNA oxidation observed in oligodendrocytes in MDD relative to normal controls suggest that
susceptibility to oxidative damage is worsened in MDD. Gene
expressions of four antioxidant genes were observed to be low
in MDD oligodendrocytes as compared to oligodendrocytes
from normal control subjects (Szebeni et al., 2014). Some of
these genes are downregulated by glucocorticoids (Pereira et al.,
1995; McIntosh et al., 1998; Schmidt et al., 2005), suggesting that
elevated stress hormones in MDD may contribute to enhanced
susceptibility of oligodendrocytes to oxidative damage in MDD.
Low levels of circulating antioxidants in MDD could conceivably also contribute to enhanced oxidative damage to normally
susceptible oligodendrocytes. Low blood levels of antioxidants,
e.g. vitamin E, glutathione, coenzyme Q, and ascorbic acid, have
been reported in depressed patients (Maes et al., 2011). However,
the impact of varying diets on levels of circulating antioxidants
is difficult to assess in studies involving human postmortem
brain tissues.
The observations of elevated gene expression of the BER
enzymes, PARP1 and OGG1, in white matter oligodendrocytes
provide additional evidence of enhanced DNA oxidation in
these cells in MDD. Gene expression of both of these enzymes
is induced by conditions of oxidative stress (Liu et al., 2000; Lan
et al., 2003; Adaikalakoteswari et al., 2007) presumably as a compensatory mechanism to enhance BER. The correlation of PARP1
and OGG1 expression levels in both glial cells from all donors in
the present study is consistent with a coordinated response of
these cells to DNA oxidation. This correlation of PARP1 and OGG1
expression levels has also been observed in dysplastic cells
from cancer patients (Dziaman et al., 2014). Extensive activity of
PARP1 depletes nicotinamide adenine dinucleotide (NAD+) and
ATP that are essential to generate PAR polymers and cells can die
from energy loss (Berger, 1985; Ha and Snyder, 1999; Fouquerel
and Sobol, 2014). In a mature myelinating oligodendrocyte,
NAD+ and ATP are critically important to myelin lipid synthesis
for the myelin sheath that encloses segments of neuronal axons.
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Hence, it is conceivable that elevated PARP activity, in response
to oxidative damage to DNA in oligodendrocytes could deplete
cellular energy supplies in MDD and interrupt important functions of these cells, particularly those that are highly energy
dependent and critical to normal neurotransmission.
While PARP1 and OGG1 are major components of the BER
apparatus, both enzymes are also involved in other cellular processes. PARP is a highly complex protein that engages in several
cellular functions, including regulation of transcription through
modifying chromatin structure, angiogenesis, mitochondrial
energy metabolism and cell division (Martínez-Bosch et al., 2016).
Of particular relevance to the study of MDD are PARP1 interactions with many transcription factors involved in regulation of
inflammatory gene expression such as nuclear factor-kappa B
(NF-KB) (Oliver et al., 1999). In fact, poly(ADP-ribosyl)ation by
PARP1 is a necessary step in the activation of NF-KB induced
by DNA damage (Stilmann et al., 2009). Recent evidence also
suggests that PAR chains, once cleaved from proteins poly(ADPribosy)lated by PARP activity, act as damage associated molecular patterns that drive inflammation (Krukenberg et al., 2015).
Likewise, recent evidence demonstrates that mice deficient
in OGG1 have impaired immune responses, and that repair of
oxidized DNA also results in an OGG1-dependent activation of
NF-KB (Aguilera-Aguirre et al., 2014). Hence, these studies demonstrate that oxidation of oligodendrocyte DNA could be an initial step in the activation of inflammatory cascades that could
contribute to further damaging effects on these and surrounding
cells, including further generation of ROS by activation of microglia. Interestingly, elevated numbers of activated microglia in
postmortem brain white matter from depressed suicide victims
have been reported (Torres-Platas et al., 2014). Collectively, these
findings contribute to growing evidence of a role of inflammation in MDD (Swardfager et al., 2016), and studies demonstrating
that anti-inflammatory compounds have therapeutic utility in
the treatment of depressive disorders (Fond et al., 2014).
Only one previous study has reported a relationship between
DNA oxidation and anhedonia in rats. Sigwalt and coworkers (2011) exposed rats to dexamethasone daily for 21 days to
induce anhedonia as measured by the sucrose preference test.
Dexamethasone-treated animals demonstrated significantly
elevated DNA oxidation in the CA1 of the hippocampus, an area
of the brain containing neurons known to particularly susceptible to oxidative damage (Wilde et al., 1997; Wang et al., 2005).
In the present study, repeated exposure to social defeat and
chronic unpredictable stress resulted in an elevation of DNA
oxidation of white matter, as well as anhedonia. While oxidative damage to white matter cells alone may be insufficient to
produce anhedonia, other susceptible brains cells such as the
hippocampus CA1 neurons may be similarly negatively affected
by psychological stress-induced oxidative damage. Regardless
of the specific cellular cause of anhedonia, elevated white matter DNA oxidation in anhedonic rats are consistent with white
matter findings in human MDD donors, reducing the likelihood
that DNA oxidation in human MDD donors is secondary to other
confounding variables (smoking, drug exposures, environmental toxin exposures, dietary variables) associated with human
postmortem tissue studies.
There are several limitations of the present study that must
be taken into consideration with regard to conclusions drawn
from the data. The sample sizes of the present study are relatively small and findings need to be replicated in a larger group
of human brain donors. While oxidative stress can regulate the
expression of PARP1, the PARP1 enzyme activity is acutely regulated by binding to damaged DNA that increases its activity by
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>500-fold (Martínez-Bosch et al., 2016). Hence, while elevated
PARP1 and OGG1 expressions were observed in MDD, PARP1
or OGG1 enzymatic activities have not been measured. PARP
activity would presumably be a difficult undertaking given
detrimental effects of the postmortem interval on enzyme
activities. Additionally, whether elevated gene expressions are
accompanied by increases in protein is not known. It is noted
that PARylation is rapidly degraded by poly(ADP-ribose) glycohydrolase (PARG) resulting in rapid downregulation of PARP1
activity (Davidovic et al., 2001). Given that, changes in PARP1
activity associated with disease may be difficult to observe
in postmortem human tissues or in blood cells from living
patients.
Numerous psychiatric and neurological disorders are associated with elevated white matter hyper-intensities and other
indicators of white matter pathology. The cellular bases of these
in vivo findings have not yet been clarified. Glia are abundant in
white matter and abnormalities in glia morphology, cell number and gene and protein expression have been described in the
postmortem human brain from MDD brain donors. The present
findings provide additional evidence of white matter pathology
in MDD, and draw attention to potential molecular mechanisms
that may be involved in the etiology of white matter pathology. Elevated BER activity in oligodendrocytes, secondary to
oxidative damage to these susceptible cells, may drive other
deleterious energy-depleting and/or inflammatory processes
that further contribute to oligodendrocyte dysfunction. Given
the critical role of oligodendrocytes in facilitating neurotransmission, disruption of oligodendrocyte function could play a
critical role in the development of depression. Searching for
compounds that could inhibit pathways activated by elevated
BER activity has the potential to unearth novel antidepressant
mechanisms.

Supplementary Material
Supplementary data are available at International Journal of
Neuropsychopharmacology online.
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